News | December 30, 2023
Venus Remedies secures marketing approval from Israel, Colombia for two oncology drugs
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
10+ emerging markets, Japan & ANZ transition in final phase
Both the India and GCC entities will be operated by separate dedicated management teams
The launch of Elores in Ecuador is expected to open the doors for the entry of the novel antibiotic adjuvant entity in other important Latin American countries
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other European countries
Augnito’s AI comprehends all English accents with 99% accuracy
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
MoU signed between AIIA and University of Amrita Vishwa Vidhyapeetham for collaboration in the field of Research and Academics in Ayurveda
The increase of stake in Aster DM Healthcare is a reiteration of the confidence in the business across geographies
Subscribe To Our Newsletter & Stay Updated
